The role of repetitive trans cranial magnetic stimulation in craving reduction among a sample of opioid use disorder patients.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202206487514449

Enrollment

Registered

2022-06-10

Start date

2022-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders

Interventions

repetitive trans cranial magnetic stimulation

sham repetitive trans cranial magnetic stimulation

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Age range: 18-45 years old Gender: males Opioid Use disorder according to the DSM-5 (early abstinence starting 1 week up to 1 month)

Exclusion criteria

Exclusion criteria: Presence of other serious mental illness (e.g.; psychotic disorders, bipolar affective disorder, depression with psychotic features). Patients with any other serious medical illness. Previous treatment with repetitive Trans- cranial magnetic stimulation. Patients with contraindications to rTMS as cardiac patient with pacemaker.

Design outcomes

Primary

Measure	Time frame
reduction in craving levels after application if 18 r-TMS sessions	—

Secondary

Measure	Time frame
relapse reduction among the sample that received real r-TMS	—

Countries

Egypt

Contacts

Public ContactNoha Ahmed

assistant lecturer of psychiatry

nohaahmedsaad@gmail.com00201227666923

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026